公开(公告)号：US20250084099A1

公开(公告)日：2025-03-13

申请号：US18638727

申请日：2024-04-18

Applicant: AbbVie Inc.

Inventor： Daniel Tzvi Cohen ,  Jane Gong ,  Tarun Jain ,  Puneet Kumar ,  Dachun Liu ,  Anthony Mastracchio ,  Mark Mills ,  Andrew William Phillips ,  John K. Pratt ,  Sreenivas Punna ,  Jennifer Ann Stockwell ,  Le Wang ,  Yiyun Yu

IPC: C07D513/04 ,  A61P35/00

Abstract: The present disclosure provides for compounds of the general Formula (I) wherein R1a, R1b, R2, R3, R4, R5, R6, R7, R8, and Ring A have any of the values defined in the specification, and pharmaceutically acceptable salts thereof.

公开(公告)号：US20230312601A1

公开(公告)日：2023-10-05

申请号：US18192810

申请日：2023-03-30

Applicant: AbbVie Inc.

Inventor： Daniel Cohen ,  Jane Gong ,  Tarun Jain ,  Puneet Kumar ,  Dachun Liu ,  Anthony Mastracchio ,  Mark Mills ,  Andrew William Phillips ,  John K. Pratt ,  Sreenivas Punna ,  Jennifer Ann Stockwell ,  Le Wang ,  Yiyun Yu

IPC: C07D513/04 ,  A61P35/00

CPC classification number: C07D513/04 ,  A61P35/00

Abstract: The present disclosure provides for compounds of the general Formula (I)




wherein R1a, R1b, R2, R3, R4, R5, R6, R7, R8, and Ring A have any of the values defined in the specification, and pharmaceutically acceptable salts thereof.